135 related articles for article (PubMed ID: 11956108)
21. Clinical implications of fibroblast activation protein in patients with colon cancer.
Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
[TBL] [Abstract][Full Text] [Related]
22. Human cervical cancer-associated nuclear matrix proteins.
Keesee SK; Marchese J; Meneses A; Potz D; Garcia-Cuellar C; Szaro RP; Solorza G; Osornio-Vargas A; Mohar A; de la Garza JG; Wu YJ
Exp Cell Res; 1998 Oct; 244(1):14-25. PubMed ID: 9770344
[TBL] [Abstract][Full Text] [Related]
23. Use of the novel marker BLCA-1 for the detection of bladder cancer.
Myers-Irvin JM; Landsittel D; Getzenberg RH
J Urol; 2005 Jul; 174(1):64-8. PubMed ID: 15947579
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer.
Leman ES; Arlotti JA; Dhir R; Greenberg N; Getzenberg RH
J Cell Biochem; 2002; 86(2):203-12. PubMed ID: 12111990
[TBL] [Abstract][Full Text] [Related]
25. Determination of molecular marker expression can predict clinical outcome in colon carcinomas.
Galizia G; Lieto E; Ferraraccio F; Orditura M; De Vita F; Castellano P; Imperatore V; Romano C; Ciardiello F; Agostini B; Pignatelli C
Clin Cancer Res; 2004 May; 10(10):3490-9. PubMed ID: 15161706
[TBL] [Abstract][Full Text] [Related]
26. Tumor cell dissemination in colon cancer does not predict extrahepatic recurrence in patients undergoing surgery for hepatic metastases.
Schoppmeyer K; Frühauf N; Oldhafer K; Seeber S; Kasimir-Bauer S
Oncol Rep; 2006 Feb; 15(2):449-54. PubMed ID: 16391868
[TBL] [Abstract][Full Text] [Related]
27. The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.
Horst D; Reu S; Kriegl L; Engel J; Kirchner T; Jung A
Cancer; 2009 May; 115(10):2063-70. PubMed ID: 19298008
[TBL] [Abstract][Full Text] [Related]
28. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
29. Nuclear matrix proteins in normal and breast cancer cells.
Khanuja PS; Lehr JE; Soule HD; Gehani SK; Noto AC; Choudhury S; Chen R; Pienta KJ
Cancer Res; 1993 Jul; 53(14):3394-8. PubMed ID: 8324750
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of humbug gene overexpression in stage II colon cancer.
Wang J; de la Monte SM; Sabo E; Kethu S; Tavares R; Branda M; Simao L; Wands JR; Resnick MB
Hum Pathol; 2007 Jan; 38(1):17-25. PubMed ID: 17020779
[TBL] [Abstract][Full Text] [Related]
31. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
[TBL] [Abstract][Full Text] [Related]
32. Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis.
Tessem MB; Selnaes KM; Sjursen W; Tranø G; Giskeødegård GF; Bathen TF; Gribbestad IS; Hofsli E
J Proteome Res; 2010 Jul; 9(7):3664-70. PubMed ID: 20507057
[TBL] [Abstract][Full Text] [Related]
33. Differential expression proteomics of human colon cancer.
Mazzanti R; Solazzo M; Fantappié O; Elfering S; Pantaleo P; Bechi P; Cianchi F; Ettl A; Giulivi C
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1329-38. PubMed ID: 16439467
[TBL] [Abstract][Full Text] [Related]
34. Altered profiles in nuclear matrix proteins associated with DNA in situ during progression of breast cancer cells.
Spencer VA; Samuel SK; Davie JR
Cancer Res; 2001 Feb; 61(4):1362-6. PubMed ID: 11245435
[TBL] [Abstract][Full Text] [Related]
35. Profiling tumor-associated autoantibodies for the detection of colon cancer.
Ran Y; Hu H; Zhou Z; Yu L; Sun L; Pan J; Liu J; Yang Z
Clin Cancer Res; 2008 May; 14(9):2696-700. PubMed ID: 18451234
[TBL] [Abstract][Full Text] [Related]
36. Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis.
Wray CM; Ziogas A; Hinojosa MW; Le H; Stamos MJ; Zell JA
Dis Colon Rectum; 2009 Aug; 52(8):1359-66. PubMed ID: 19617745
[TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
38. Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer.
Boccardo F; Rubagotti A; Carmignani G; Romagnoli A; Nicolò G; Barboro P; Parodi S; Patrone E; Balbi C
Prostate; 2003 Jun; 55(4):259-64. PubMed ID: 12712405
[TBL] [Abstract][Full Text] [Related]
39. Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer.
Chang H; Su JM; Huang CC; Liu LC; Tsai CH; Chou MC; Lin P
Cancer Detect Prev; 2005; 29(6):562-9. PubMed ID: 16289386
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and genotype identification of human JC virus in colon cancer in Taiwan.
Lin PY; Fung CY; Chang FP; Huang WS; Chen WC; Wang JY; Chang D
J Med Virol; 2008 Oct; 80(10):1828-34. PubMed ID: 18712832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
